knowledge -WSS

knowledge

author：comprehensive 2025-10-01 23:58:07 - browse：8421

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 2 US Navy sailors arrested for allegedly spying for China

WSS

Humana, CVS hope to turn members into patients at clinics

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Stem cell clinics for heart failure: buyer be wary

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

White House drug shortage group privately met with industry

hotspot

knowledge

entertainment

Hollywood unions extend contract negotiations for actors

Microsoft strikes partnership with Duke Health to advance health AI

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How CRISPR works, explained in two minutes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

With heat waves through August, officials warn of health risks

Affirmative action in medical school literally saved lives

A cyberattack has disrupted hospitals and health care in several states

Medical records are filled with copy

Stem cell clinics for heart failure: buyer be wary

knowledge

White House drug shortage group privately met with industry

'Brian's Song' at 50 still offers lessons about cancer for today

OTC birth control: A brief history of over the counter pill design

'Brian's Song' at 50 still offers lessons about cancer for today

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Slovenia has suffered its worst

hotspot

leisure time

entertainment

hotspot